An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.

[1]  K. Kuča,et al.  Inhibition of blood cholinesterases following intoxication with VX and its derivatives , 2007, Journal of applied toxicology : JAT.

[2]  J. Mikler,et al.  Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. , 2007, Toxicology.

[3]  E. M. Jakubowski,et al.  Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats. , 2007, Toxicology.

[4]  T. S. Moran,et al.  Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX. , 2007, Toxicology and applied pharmacology.

[5]  H. Morita,et al.  Sarin experiences in Japan: Acute toxicity and long-term effects , 2006, Journal of the Neurological Sciences.

[6]  P. Eyer,et al.  Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. , 2006, Toxicology.

[7]  E. Duysen,et al.  Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. , 2005, Biochemical pharmacology.

[8]  E. Clarkson,et al.  In vivo skin absorption and distribution of the nerve agent VX (O–ethyl–S–[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig , 2005, Human & experimental toxicology.

[9]  T. Satoh,et al.  Extremely sensitive biomarker of acute organophosphorus insecticide exposure , 2005, Human & experimental toxicology.

[10]  Z. Janka,et al.  Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. , 2004, Life sciences.

[11]  A. Niven,et al.  Inhalational exposure to nerve agents. , 2004, Respiratory care clinics of North America.

[12]  Z. Janka,et al.  Serum butyrylcholinesterase activity in hyperlipidaemia. , 2004, Atherosclerosis.

[13]  H. Benschop,et al.  Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. , 2003, Toxicology and applied pharmacology.

[14]  I. Hill,et al.  Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig , 2003, Human & experimental toxicology.

[15]  K. Dave,et al.  Effect of alloxan-induced diabetes on serum and cardiac butyrylcholinesterases in the rat. , 2002, The Journal of endocrinology.

[16]  D. Bevan,et al.  Increased plasma cholinesterase activity and mivacurium resistance: report of a family. , 1999, Anesthesia and analgesia.

[17]  G. Cassel,et al.  Toxicokinetics of soman in cerebrospinal fluid and blood of anaesthetized pigs , 1998, Archives of Toxicology.

[18]  J. Toutant,et al.  Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development. , 1994, European journal of biochemistry.

[19]  P. Gustin,et al.  Altered capillary filtration coefficient in parathion- and paraoxon-induced edema in isolated and perfused rabbit lungs. , 1992, Toxicology and applied pharmacology.

[20]  C. Furlong,et al.  Purification of rabbit and human serum paraoxonase. , 1991, Biochemistry.

[21]  G. Benchetrit,et al.  Mechanisms of Pulmonary Edema Induced by an Organophosphorus Compound in Anesthetized Dogs , 1991 .

[22]  R. Busuttil,et al.  Atypical serum cholinesterase eliminated by orthotopic liver transplantation. , 1987, Anesthesiology.

[23]  W. Kalow,et al.  The plasma cholinesteerases: a new perspective. , 1981, Advances in clinical chemistry.

[24]  F. Sidell,et al.  The reactivatibility of cholinesterase inhibited by VX and sarin in man. , 1974, Toxicology and applied pharmacology.

[25]  M. Karnovsky,et al.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[27]  V. Sim,et al.  Intravenous Administration of VX in Man , 1960 .